69 related articles for article (PubMed ID: 12643760)
1. Mutants of immunotoxin anti-Tac(dsFv)-PE38 with variable number of lysine residues as candidates for site-specific chemical modification. 1. Properties of mutant molecules.
Onda M; Vincent JJ; Lee B; Pastan I
Bioconjug Chem; 2003; 14(2):480-7. PubMed ID: 12643760
[TBL] [Abstract][Full Text] [Related]
2. Mutations of two lysine residues in the CDR loops of a recombinant immunotoxin that reduce its sensitivity to chemical derivatization.
Benhar I; Brinkmann U; Webber KO; Pastan I
Bioconjug Chem; 1994; 5(4):321-6. PubMed ID: 7948099
[TBL] [Abstract][Full Text] [Related]
3. Lowering the isoelectric point of the Fv portion of recombinant immunotoxins leads to decreased nonspecific animal toxicity without affecting antitumor activity.
Onda M; Nagata S; Tsutsumi Y; Vincent JJ; Wang Q; Kreitman RJ; Lee B; Pastan I
Cancer Res; 2001 Jul; 61(13):5070-7. PubMed ID: 11431343
[TBL] [Abstract][Full Text] [Related]
4. Comparison of recombinant immunotoxins against LeY antigen expressing tumor cells: influence of affinity, size, and stability.
Bera TK; Pastan I
Bioconjug Chem; 1998; 9(6):736-43. PubMed ID: 9815167
[TBL] [Abstract][Full Text] [Related]
5. Improved cytotoxic activity toward cell lines and fresh leukemia cells of a mutant anti-CD22 immunotoxin obtained by antibody phage display.
Salvatore G; Beers R; Margulies I; Kreitman RJ; Pastan I
Clin Cancer Res; 2002 Apr; 8(4):995-1002. PubMed ID: 11948105
[TBL] [Abstract][Full Text] [Related]
6. Expression of an anti-CD3 single-chain immunotoxin with a truncated diphtheria toxin in a mutant CHO cell line.
Liu YY; Gordienko I; Mathias A; Ma S; Thompson J; Woo JH; Neville DM
Protein Expr Purif; 2000 Jul; 19(2):304-11. PubMed ID: 10873546
[TBL] [Abstract][Full Text] [Related]
7. Identification of a specific tyrosine residue in Bryodin 1 distinct from the active site but required for full catalytic and cytotoxic activity.
Fryxell DK; Gawlak SL; Dodge RW; Siegall CB
Protein Sci; 1998 Feb; 7(2):318-24. PubMed ID: 9521107
[TBL] [Abstract][Full Text] [Related]
8. Disulfide stabilization of antibody Fv: computer predictions and experimental evaluation.
Reiter Y; Brinkmann U; Jung SH; Pastan I; Lee B
Protein Eng; 1995 Dec; 8(12):1323-31. PubMed ID: 8869646
[TBL] [Abstract][Full Text] [Related]
9. A recombinant immunotoxin containing a disulfide-stabilized Fv fragment.
Brinkmann U; Reiter Y; Jung SH; Lee B; Pastan I
Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7538-42. PubMed ID: 8356052
[TBL] [Abstract][Full Text] [Related]
10. Streptavidin in antibody pretargeting. 4. Site-directed mutation provides evidence that both arginine and lysine residues are involved in kidney localization.
Wilbur DS; Hamlin DK; Sanderson J; Lin Y
Bioconjug Chem; 2004; 15(6):1454-63. PubMed ID: 15546215
[TBL] [Abstract][Full Text] [Related]
11. Site-specific chemical modification with polyethylene glycol of recombinant immunotoxin anti-Tac(Fv)-PE38 (LMB-2) improves antitumor activity and reduces animal toxicity and immunogenicity.
Tsutsumi Y; Onda M; Nagata S; Lee B; Kreitman RJ; Pastan I
Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8548-53. PubMed ID: 10890891
[TBL] [Abstract][Full Text] [Related]
12. Improved stability and yield of Fv targeted superantigen by introducing both linker and disulfide bond into the targeting moiety.
Hao HJ; Jiang YQ; Zheng YL; Ma R; Yu DW
Biochimie; 2005 Aug; 87(8):661-7. PubMed ID: 15927340
[TBL] [Abstract][Full Text] [Related]
13. Purification of clinical-grade disulfide stabilized antibody fragment variable--Pseudomonas exotoxin conjugate (dsFv-PE38) expressed in Escherichia coli.
Jiang H; Xie Y; Burnette A; Roach J; Giardina SL; Hecht TT; Creekmore SP; Mitra G; Zhu J
Appl Microbiol Biotechnol; 2013 Jan; 97(2):621-32. PubMed ID: 22890777
[TBL] [Abstract][Full Text] [Related]
14. Redesigning the reactive site loop of the wheat subtilisin/chymotrypsin inhibitor (WSCI) by site-directed mutagenesis. A protein-protein interaction study by affinity chromatography and molecular modeling.
Bruni N; Di Maro A; Costantini S; Chambery A; Facchiano AM; Ficca AG; Parente A; Poerio E
Biochimie; 2009 Sep; 91(9):1112-22. PubMed ID: 19500644
[TBL] [Abstract][Full Text] [Related]
15. Investigation of the detoxification mechanism of formaldehyde-treated tetanus toxin.
Thaysen-Andersen M; Jørgensen SB; Wilhelmsen ES; Petersen JW; Højrup P
Vaccine; 2007 Mar; 25(12):2213-27. PubMed ID: 17240009
[TBL] [Abstract][Full Text] [Related]
16. Structure-function engineering of interferon-beta-1b for improving stability, solubility, potency, immunogenicity, and pharmacokinetic properties by site-selective mono-PEGylation.
Basu A; Yang K; Wang M; Liu S; Chintala R; Palm T; Zhao H; Peng P; Wu D; Zhang Z; Hua J; Hsieh MC; Zhou J; Petti G; Li X; Janjua A; Mendez M; Liu J; Longley C; Zhang Z; Mehlig M; Borowski V; Viswanathan M; Filpula D
Bioconjug Chem; 2006; 17(3):618-30. PubMed ID: 16704199
[TBL] [Abstract][Full Text] [Related]
17. Site-specific PEGylation of a lysine-deficient TNF-alpha with full bioactivity.
Yamamoto Y; Tsutsumi Y; Yoshioka Y; Nishibata T; Kobayashi K; Okamoto T; Mukai Y; Shimizu T; Nakagawa S; Nagata S; Mayumi T
Nat Biotechnol; 2003 May; 21(5):546-52. PubMed ID: 12665803
[TBL] [Abstract][Full Text] [Related]
18. Lysine-deficient lymphotoxin-α mutant for site-specific PEGylation.
Narimatsu S; Yoshioka Y; Watanabe H; Masano T; Morishige T; Yao X; Tanabe A; Tsunoda S; Tsutsumi Y; Mukai Y; Okada N; Nakagawa S
Cytokine; 2011 Nov; 56(2):489-93. PubMed ID: 21871814
[TBL] [Abstract][Full Text] [Related]
19. Site-directed enzymatic PEGylation of the human granulocyte colony-stimulating factor.
Maullu C; Raimondo D; Caboi F; Giorgetti A; Sergi M; Valentini M; Tonon G; Tramontano A
FEBS J; 2009 Nov; 276(22):6741-50. PubMed ID: 19843182
[TBL] [Abstract][Full Text] [Related]
20. Lys296 and Arg299 residues in the C-terminus of MD-ACO1 are essential for a 1-aminocyclopropane-1-carboxylate oxidase enzyme activity.
Yoo A; Seo YS; Jung JW; Sung SK; Kim WT; Lee W; Yang DR
J Struct Biol; 2006 Dec; 156(3):407-20. PubMed ID: 17046279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
